More than 150 scientists, public officials, family members of people with schizophrenia and other interested parties gathered in Nyack, N.Y., for the National Alliance for the Mentally Ill Families and Friends of the Nathan Kline Institute (NKI) for Psychiatric...

Funded by the National Association for Research on Schizophrenia and Depression (NARSAD), A. Eden Evins, M.D., is examining effects of combined bupropion (Zyban) and cognitive-behavioral therapy (CBT) on smoking reduction in patients with schizophrenia. Evins,...

The role of the thalamus in schizophrenia is being investigated by Eileen Kemether, M.D., associate researcher in the department of psychiatry at Mount Sinai School of Medicine, with the support of the National Alliance for Research on Schizophrenia and Depression...

With funding from the National Alliance for Research on Schizophrenia and Depression (NARSAD), Sean Flynn, M.D., assistant professor of psychiatry at the University of British Columbia, is using novel magnetic resonance imaging (MRI) techniques to examine...

With a grant from the National Association for Research on Schizophrenia and Depression (NARSAD), Cynthia Shannon-Weickert, Ph.D., is studying postmortem brains of people with schizophrenia to test the theory that the illness is a developmental disorder triggered or...

Postmortem studies have identified hippocampal abnormalities in brains of individuals with schizophrenia, but possible limitations of those studies include chronicity of illness and long-term exposure to antipsychotic medications, according to Philip R. Szeszko,...

A study using nicotine to modulate antipsychotic-induced movement disorders including dyskinesias and neuroleptic-induced parkinsonism (NIP) is being conducted by Gregory W. Dalack, M.D., associate professor of psychiatry at the University of Michigan. The work is...

With a Dana Foundation grant totaling $100,000 for two years, researchers at Yale and Emory Universities are planning a study using fluorodeoxyglucose positron emission tomography (FDG PET) and repetitive transcranial magnetic stimulation (rTMS) to treat patients with...

“What’s interesting is that while positive symptoms do get most of the play in the media, and when you think about schizophrenia those are the first things you think about,” W. Gordon Frankle, M.D., explained, “it’s really these cognitive impairments that have been...